HESTERBIO₹2,056.60-4.20%
81/100
0100 · strongest
strong
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %HESTERBIO financial summary
For Mar 2026, Hester Biosciences Ltd reported revenue of ₹292 crore, which grew 2.1% from the previous year. Net profit was ₹52 crore, which grew 62.5% year on year, on an operating margin of 25%. Earnings per share came in at ₹61.24. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹292 crore |
|---|---|
| Net profit | ₹52 crore |
| Operating margin | 25% |
| EPS | ₹61.24 |